Citations refer to the original publication, not to a Scieee localized version.
Pladevall Morera, D., Castejón Griñán, M., Aguilera, P., Gaardahl, K., Ingham, A., Brosnan Cashman, J. A., Meeker, A. K., & López Contreras, A. J. (2022). ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. MDPI. https://doi.org/10.3390/cancers14071790
Pladevall Morera, David, et al. ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. MDPI, 2022. https://doi.org/10.3390/cancers14071790.
Pladevall Morera, David, María Castejón Griñán, Paula Aguilera, Karina Gaardahl, Andreas Ingham, Jacqueline A. Brosnan Cashman, Alan K. Meeker, and Andrés J. López Contreras. ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. MDPI, 2022. https://doi.org/10.3390/cancers14071790.
Pladevall Morera, D. et al. (2022) ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. MDPI. Available at: https://doi.org/10.3390/cancers14071790.
D. Pladevall Morera et al., “ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors,” MDPI, 2022, doi: 10.3390/cancers14071790.
@misc{pladevallmorera2022atrxdeficient,
author = {Pladevall Morera, David and Castejón Griñán, María and Aguilera, Paula and Gaardahl, Karina and Ingham, Andreas and Brosnan Cashman, Jacqueline A. and Meeker, Alan K. and López Contreras, Andrés J.},
title = {ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors},
year = {2022},
publisher = {MDPI},
doi = {10.3390/cancers14071790},
url = {https://doi.org/10.3390/cancers14071790}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
